NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Tyson Q4 Profit Jumps; Beef Faces $600M Loss, Trump Scrutiny

Tyson Foods (TSN) reported growth in sales and adjusted profit for Fiscal 2025, driven by strong Chicken and Prepared Foods segments, despite major losses in Beef due to severe cattle shortages and rising prices.

Tyson Q4 Profit Jumps; Beef Faces $600M Loss, Trump Scrutiny
Photo by Cristi Caval on Unsplash
Already have an account? Sign in.
11/10/2025 · 8:16 AM
TSN
/ Read more

Feed↓

Wall Street Boosts Compass Pathways as COMP360 Durability Data Strengthens Path to 2027 Approval
Featured/ 07/08/2026 · 10:10 AM

Wall Street Boosts Compass Pathways as COMP360 Durability Data Strengthens Path to 2027 Approval

Positive six-month COMP360 results trigger analyst upgrades and higher price targets for Compass Pathways. Strong durability data clears path to potential 2027 FDA approval in treatment-resistant depression.

/ Subscriber only
William Blair Initiates Outperform Coverage on Zura Bio, Citing Strong Potential for Tibulizumab
07/08/2026 · 9:32 AM

William Blair Initiates Outperform Coverage on Zura Bio, Citing Strong Potential for Tibulizumab

William Blair cites strong upside potential for lead candidate tibulizumab in hidradenitis suppurativa and systemic sclerosis.

/ Subscriber only
Chemomab Merges with Scipher Medicine to Advance AI-Powered Precision Treatment for Rheumatoid Arthritis
07/08/2026 · 8:50 AM

Chemomab Merges with Scipher Medicine to Advance AI-Powered Precision Treatment for Rheumatoid Arthritis

Chemomab and Scipher Medicine announce merger to develop nebokitug, a first-in-class anti-CCL24 antibody, in an AI-driven Phase 2 trial for rheumatoid arthritis. $30M new funding secured.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe